Dose-Response Relationships for Hemidiaphragmatic Paresis Following Ultrasound-Guided Supraclavicular Block

Completed · Phase 4

Conditions studied: Surgery of Right Upper Extremity

In brief

This clinical trial is for subjects undergoing right upper extremity surgery. The aim of the study is to investigate the dose-response relationship between local anesthetic volume and ipsilateral hemidiaphragmatic paresis (HDP) in patients getting ultrasound-guided supraclavicular brachial plexus blocks in a blinded, prospective trial.

Key facts

Study ID

NCT03138577

Run by

Weill Medical College of Cornell University

People needed

24

Starts

2018-02-12

Expected to finish

2019-07-30

Last updated by the study team

2020-05-13

Who can join

Age: 18 and older, up to 105. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Undergoing right upper extremity surgery with supraclavicular block as the primary anesthetic
• Age greater than or equal to 18 years of age
• American Society of Anesthesiologists (ASA) physical status 1 to 3
• Able to give informed consent

You may not qualify if…

• Patient refusal for supraclavicular block
• Inability to give informed consent
• Allergy to local anesthetics
• Hemidiaphragmatic dysfunction, suspected or known pulmonary disease
• Neuromuscular disease
• Obstructive or restrictive pulmonary disease
• Medical or anatomic contraindication to supraclavicular blockade as judged by clinician
• Pregnancy

Where it is running

• Weill Cornell Medical College — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.